Published: Mar 16, 2022
Focus:
Growth Capital
We are delighted to share the Spring issue of Maven's VCT investor magazine with you.
In this edition of Creating Value, we cover the latest new investments completed by the Maven VCTs, including in emerging baby care brand Pura, and healthcare analytics specialist RwHealth.
Also featured are two recent profitable realisations from the VCT portfolio following sales to trade or equity buyers, with the exit from Quorum Cyber generating a money multiple return of 6.5x cost, and the sale of Optoscribe which is expected to deliver a money multiple return of 2.29x cost when full proceeds are received.
Later in the magazine, we feature a guest article from Gareth Lewis, CEO at VCT investee Delio, on how that business is helping financial institutions make alternative assets more accessible to investors. In addition, with the tax year end less than a month away, we discuss the attractions of dividends as a supplementary source of income for VCT investors.
Finally, we provide an update on the positive progress made by some other VCT portfolio companies, with a number achieving transformational growth through innovative technologies that are helping to meet changing business and consumer needs.
